Document is current
Any future updates will be listed below
-
Authors
Perlstein, Itay
Meyer, Jonathan
Kumar, Sharath
Yue, Ziqi
Ivaturi, Vijay
Franzenburg, Kelli R.
Suett, Mark
Hansen, Rolf
Merenlender Wagner, Avia
Phatak, Arti
Singh, Rajendra https://orcid.org/0000-0003-2719-4573
-
Funding
Funding for this research was provided by:
Teva Branded Pharmaceutical Products R&D LLC
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 1 October 2025
First Online: 26 October 2025
Declarations
:
: This study was supported by funding from Teva Branded Pharmaceutical Products R&D LLC. Itay Perlstein and Jonathan Meyer have received consultancy fees or honoraria from Teva Pharmaceuticals in relation to this study. Sharath Kumar and Vijay Ivaturi are employees of Pumas-AI Inc., which has received payments from Teva Pharmaceuticals in relation to this study. Ziqi Yue was an employee of Pumas-AI Inc., at the completion of the study and is now affiliated with Beacon Hill Solutions Group LLC. Kelli R. Franzenburg, Mark Suett, Rolf Hansen, Avia Merenlender Wagner, Arti Phatak, and Rajendra Singh are employees and shareholders of Teva Pharmaceuticals.
: This article is based on previously conducted studies and does not contain any new studies with human participants. All involved study centers of the original clinical trials received approval by local ethics committees and informed consent was received for all patients. Consent was obtained during the original clinical trials, and no new consent forms were required/collected for this analysis.
